Constantin, Theodora A.
Varela-Carver, Anabel
Greenland, Kyle K.
de Almeida, Gilberto Serrano
Olden, Ellen
Penfold, Lucy
Ang, Simon
Ormrod, Alice
Leach, Damien A.
Lai, Chun-Fui
Ainscow, Edward K.
Bahl, Ash K.
Carling, David
Fuchter, Matthew J. http://orcid.org/0000-0002-1767-7072
Ali, Simak http://orcid.org/0000-0002-1320-0816
Bevan, Charlotte L. http://orcid.org/0000-0002-7533-0552
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N014103/1, MR/N014103/1, MR/R015732/1)
Imperial College Presidents Award
Prostate Cancer UK (RIA17-ST2-001, RIA17-ST2-001, RIA19-ST2-004, RIA19-ST2-004, RIA19-ST2-004)
Article History
Received: 20 July 2022
Revised: 15 March 2023
Accepted: 21 March 2023
First Online: 19 April 2023
Change Date: 14 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-024-02606-w
Competing interests
: GSdA was previously supported by a research grant from Carrick Therapeutics Ltd to CLB. EO is funded by a MRC iCASE Enterprise studentship in partnership with Carrick Therapeutics Ltd. S Ali is a named inventor on CDK7 inhibitor patents that have been licensed to Carrick Therapeutics Ltd and has received royalty payments, shares, and research funding from Carrick Therapeutics. MJF is a named inventor on CDK7 inhibitor patents that have been licensed to Carrick Therapeutics Ltd and has received royalty payments from Carrick Therapeutics. AKB and EC are/were at the time of this study employees of Carrick Therapeutics. The following authors declare that they have no competing interests: TAC, AV-C, KKG, LP, S Ang, AO, DC, C-FL, DAL.
: All mouse experiments were carried out by licensed investigators in accordance with the UK Home Office Guidance on the Operation of the Animal (Scientific Procedures) Act 1986 (HMSO, London, UK, 1990).
: Not applicable.